New Delhi: Researchers at the University of Dundee are set to receive £30 million in funding over the next five years to continue their work into developing new treatments for a range of conditions, including cancer and Parkinson’s, a government press release stated.
The Medical Research Council’s Protein Phosphorylation and Ubiquitylation Unit (MRC PPU) will receive funding from the UK government. The research team, which has a track record of developing innovative therapies, has already received £60 million in private investment for its work.
Study co-author Professor Dario Alessi, Director of the MRC PPU, said: “We are incredibly grateful for the long-term support that our Unit has received from the MRC over the last 34 years.”
“This has enabled our researchers to tackle the most important questions and greatly contributed to our understanding of how derailment of biological pathways causes human diseases including neurodegeneration, diabetes, cancer, and immune dysfunction,” the author added.
Science and Technology Secretary Peter Kyle shared his personal experience and said, “I went to university later in life than most, but when I did it changed everything for me. It was the first time in my life that people saw potential in me that I never knew I had, and gave me the support and focus I needed to build something from it.”
“The value of our universities, to the economy and the whole of society, cannot be overstated,” he added.